{"title":"特发性血小板减少性紫癜患者小细胞肺癌的化疗","authors":"Ryoko Ogawa, Hiroaki Satoh, Yukio Ishii, Morio Ohtsuka","doi":"10.1016/j.rmedx.2007.06.001","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Thrombocytopenia is one of the most important and serious co-morbid conditions in patients with </span>hematological malignancies<span><span><span> as well as non-hematological solid tumors. We report herein a </span>small cell lung cancer (SCLC) patient with idiopathic thrombocytopenic purpura (ITP) who was successfully treated with chemotherapy containing </span>cisplatin and </span></span>etoposide. It is probably safe to administer chemotherapeutic agents for some cancer patients with ITP, but prevention or minimization of toxicities of these chemotherapeutic agents is very important. Full consideration about the indication of chemotherapy and careful observation are required for such patients.</p></div>","PeriodicalId":101082,"journal":{"name":"Respiratory Medicine Extra","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rmedx.2007.06.001","citationCount":"1","resultStr":"{\"title\":\"Chemotherapy for small cell lung cancer in a patient with idiopathic thrombocytopenic purpura\",\"authors\":\"Ryoko Ogawa, Hiroaki Satoh, Yukio Ishii, Morio Ohtsuka\",\"doi\":\"10.1016/j.rmedx.2007.06.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Thrombocytopenia is one of the most important and serious co-morbid conditions in patients with </span>hematological malignancies<span><span><span> as well as non-hematological solid tumors. We report herein a </span>small cell lung cancer (SCLC) patient with idiopathic thrombocytopenic purpura (ITP) who was successfully treated with chemotherapy containing </span>cisplatin and </span></span>etoposide. It is probably safe to administer chemotherapeutic agents for some cancer patients with ITP, but prevention or minimization of toxicities of these chemotherapeutic agents is very important. Full consideration about the indication of chemotherapy and careful observation are required for such patients.</p></div>\",\"PeriodicalId\":101082,\"journal\":{\"name\":\"Respiratory Medicine Extra\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rmedx.2007.06.001\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory Medicine Extra\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1744904907000343\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine Extra","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1744904907000343","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Chemotherapy for small cell lung cancer in a patient with idiopathic thrombocytopenic purpura
Thrombocytopenia is one of the most important and serious co-morbid conditions in patients with hematological malignancies as well as non-hematological solid tumors. We report herein a small cell lung cancer (SCLC) patient with idiopathic thrombocytopenic purpura (ITP) who was successfully treated with chemotherapy containing cisplatin and etoposide. It is probably safe to administer chemotherapeutic agents for some cancer patients with ITP, but prevention or minimization of toxicities of these chemotherapeutic agents is very important. Full consideration about the indication of chemotherapy and careful observation are required for such patients.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
